AIA Group Ltd Grows Holdings in Cigna Group $CI

AIA Group Ltd increased its holdings in Cigna Group (NYSE:CI) by 408.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,947 shares of the health services provider’s stock after acquiring an additional 28,877 shares during the quarter. AIA Group Ltd’s holdings in Cigna Group were worth $10,362,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently bought and sold shares of the business. Harbor Capital Advisors Inc. increased its stake in shares of Cigna Group by 119.5% during the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after purchasing an additional 49 shares in the last quarter. Collier Financial bought a new stake in shares of Cigna Group in the 3rd quarter worth approximately $34,000. Traub Capital Management LLC purchased a new stake in shares of Cigna Group in the 2nd quarter worth approximately $48,000. Founders Capital Management grew its stake in shares of Cigna Group by 53.0% in the 3rd quarter. Founders Capital Management now owns 153 shares of the health services provider’s stock worth $44,000 after buying an additional 53 shares during the last quarter. Finally, Twin Peaks Wealth Advisors LLC bought a new position in Cigna Group during the 2nd quarter valued at approximately $52,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Stock Up 0.5%

CI stock opened at $264.87 on Thursday. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The business has a fifty day moving average price of $278.57 and a 200-day moving average price of $282.09. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74. The stock has a market capitalization of $69.80 billion, a P/E ratio of 11.94, a P/E/G ratio of 0.91 and a beta of 0.27.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company had revenue of $72.50 billion for the quarter, compared to analysts’ expectations of $69.53 billion. During the same period last year, the firm posted $6.64 earnings per share. Cigna Group’s revenue was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Equities analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be paid a $1.56 dividend. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date is Thursday, March 5th. Cigna Group’s dividend payout ratio (DPR) is presently 28.13%.

Insider Activity at Cigna Group

In other news, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares of the company’s stock, valued at $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the transaction, the insider owned 32,647 shares in the company, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.70% of the stock is owned by insiders.

Analyst Ratings Changes

Several equities research analysts have commented on CI shares. Guggenheim reissued a “buy” rating and issued a $318.00 target price on shares of Cigna Group in a report on Monday, February 2nd. Mizuho set a $325.00 price target on Cigna Group in a report on Friday, January 9th. Royal Bank Of Canada lowered their price target on Cigna Group from $344.00 to $333.00 and set an “outperform” rating for the company in a research report on Friday, February 6th. Robert W. Baird dropped their price target on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research note on Thursday, December 11th. Finally, Leerink Partners increased their price objective on shares of Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a research report on Friday, February 6th. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $333.11.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.